Advisor to Douglas Pharmaceuticals on  acquiring Vital Foods Phloe® for NZ - Sept 2015Advisors to CMT,an Aura Capital Oy company on assets divestment to Yokogawa- June 2015Advisor to Major US Pharma Corp on successful sale of Manufacturing Plant - May 2015Advisor to ESTEVE on Pharma licensing E-58245, a new therapeutic product for pain - December 2014Advisor to MedGenesis in their Parkinson's Disease agreement with Pfizer - September 2014Advisor on Pharma deal terms to Plethora on PSD502 licensing agreement - Sept 2014Advisor to Medical Insight on its sale to Karos Health - June 2014Advisor to major US pharma corporation sale of its biologics facility - May 2014Advisor to Novartis on future of its UK Horsham campus - April 2014Advisor to Nanosight in its sale to Spectris plc - 2013Advisor to Dogu Tip in its sale to Gulf Capital - 2013Advisor to Sanofi in the sale of its Slovakian pharmaceutical company to Wood & Co. - 2013Advisor to Merck on the sale of its UK R&D facility
Due diligence, expert testimony and dispute resolution Valuation, bench marking and strategy Business development services: in-licensing and out-licensing Sell side and buy side advisory, deal structuring and negotiation support

Global expertise in pharma M&A and licensing

We have a successful track record in transaction outcomes in both pharma M&A and licensing. Our expertise brings a unique strategic and commercial insight within healthcare. This makes us ideally placed to support your business from strategic development, through to valuation/deal terms and, utlimately, to getting the deal done.

We offer a comprehensive range of deal related healthcare advisory services and we are trusted to deliver quality results to our clients. Our clients range from blue-chip corporations to small start-up entities across the globe. Our coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. We are are also active in the CRO and CMO M&A. See what our clients say here.

Our experience of 23 years is gained from working with clients' M&A and licensing in 38 countries and conducting more than 700 assignments.